Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype

被引:27
作者
Oh, Ki [1 ]
Yoo, Yun Jae [1 ]
Torre-Healy, Luke A. [1 ]
Rao, Manisha [2 ,3 ]
Fassler, Danielle [1 ]
Wang, Pei [4 ]
Caponegro, Michael [5 ]
Gao, Mei [6 ]
Kim, Joseph [6 ]
Sasson, Aaron [7 ,8 ]
Georgakis, Georgios [7 ,8 ]
Powers, Scott [3 ,8 ]
Moffitt, Richard A. [1 ,9 ,10 ]
机构
[1] SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY USA
[3] SUNY Stony Brook, Dept Pathol, Stony Brook, NY USA
[4] Univ Texas Hlth Sci Ctr, Dept Cell Syst & Anat, San Antonio, TX USA
[5] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY USA
[6] Univ Kentucky, Dept Surg, Lexington, KY USA
[7] SUNY Stony Brook, Dept Surg, Stony Brook, NY USA
[8] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY USA
[9] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[10] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
WHOLE-TRANSCRIPTOME ANALYSIS; T-CELLS; EXPRESSION; ADENOCARCINOMA; INHIBITION; GENE; DIFFERENTIATION; ACTIVATION; REVEALS;
D O I
10.1038/s41467-023-40895-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bulk analyses of pancreatic ductal adenocarcinoma (PDAC) samples are complicated by the tumor microenvironment (TME), i.e. signals from fibroblasts, endocrine, exocrine, and immune cells. Despite this, we and others have established tumor and stroma subtypes with prognostic significance. However, understanding of underlying signals driving distinct immune and stromal landscapes is still incomplete. Here we integrate 92 single cell RNA-seq samples from seven independent studies to build a reproducible PDAC atlas with a focus on tumor-TME interdependence. Patients with activated stroma are synonymous with higher myofibroblastic and immunogenic fibroblasts, and furthermore show increased M2-like macrophages and regulatory T-cells. Contrastingly, patients with 'normal' stroma show M1-like recruitment, elevated effector and exhausted T-cells. To aid interoperability of future studies, we provide a pretrained cell type classifier and an atlas of subtype-based signaling factors that we also validate in mouse data. Ultimately, this work leverages the heterogeneity among single-cell studies to create a comprehensive view of the orchestra of signaling interactions governing PDAC. Multiple studies have characterised the tumour microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) using single-cell RNA-seq. Here, the authors integrate the data from such single-cell studies to provide a cohesive analysis of the PDAC TME, revealing cell types and interactions that are associated with PDAC phenotypes.
引用
收藏
页数:13
相关论文
共 98 条
[81]   Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype model [J].
Torre-Healy, Luke A. ;
Kawalerski, Ryan R. ;
Oh, Ki ;
Chrastecka, Lucie ;
Peng, Xianlu L. ;
Aguirre, Andrew J. ;
Rashid, Naim U. ;
Yeh, Jen Jen ;
Moffitt, Richard A. .
COMMUNICATIONS BIOLOGY, 2023, 6 (01)
[82]  
Trapnell Cole., 2017, Monocle: Cell counting, differential expression, and trajectory analysis for single-cell RNA-Seq experiments
[83]  
Turnquist HR, 2007, INT J ONCOL, V30, P631
[84]   Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies [J].
Waibl Polania, Jessica ;
Lerner, Emily C. ;
Wilkinson, Daniel S. ;
Hoyt-Miggelbrink, Alexandra ;
Fecci, Peter E. .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[85]   Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response [J].
Wang, Yu ;
Liang, Yiyi ;
Xu, Haiyan ;
Zhang, Xiao ;
Mao, Tiebo ;
Cui, Jiujie ;
Yao, Jiayu ;
Wang, Yongchao ;
Jiao, Feng ;
Xiao, Xiuying ;
Hu, Jiong ;
Xia, Qing ;
Zhang, Xiaofei ;
Wang, Xujun ;
Sun, Yongwei ;
Fu, Deliang ;
Shen, Lei ;
Xu, Xiaojiang ;
Xue, Jing ;
Wang, Liwei .
CELL DISCOVERY, 2021, 7 (01)
[86]   A randomized phase II study of cabiralizumab (cabira) plus nivolumab (vivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC). [J].
Wang-Gillam, Andrea ;
O'Reilly, Eileen Mary ;
Bendell, Johanna C. ;
Wainberg, Zev A. ;
Borazanci, Erkut Hasan ;
Bahary, Nathan ;
O'Hara, Mark H. ;
Beatty, Gregory Lawrence ;
Pant, Shubham ;
Cohen, Deirdre Jill ;
Leong, Stephen ;
Beg, Muhammad Shaalan ;
Yu, Kenneth H. ;
Evans, T. R. Jeffry ;
Seufferlein, Thomas ;
Okusaka, Takuji ;
Phillips, Penny ;
Liu, Xuan ;
Perna, Serena K. ;
Le, Dung T. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[87]   The tumor microenvironment and its role in promoting tumor growth [J].
Whiteside, T. L. .
ONCOGENE, 2008, 27 (45) :5904-5912
[88]   Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity [J].
Williams, Hannah L. ;
Costa, Andressa Dias ;
Zhang, Jinming ;
Raghavan, Srivatsan ;
Winter, Peter S. ;
Kapner, Kevin S. ;
Ginebaugh, Scott P. ;
Vayrynen, Sara A. ;
Vayrynen, Juha P. ;
Yuan, Chen ;
Navia, Andrew W. ;
Wang, Junning ;
Yang, Annan ;
Bosse, Timothy L. ;
Kalekar, Radha L. ;
Lowder, Kristen E. ;
Lau, Mai Chan ;
Elganainy, Dalia ;
Morales-Oyarvide, Vicente ;
Rubinson, Douglas A. ;
Singh, Harshabad ;
Perez, Kimberly ;
Cleary, James M. ;
Clancy, Thomas E. ;
Wang, Jiping ;
Mancias, Joseph D. ;
Brais, Lauren K. ;
Hill, Emma R. ;
Kozak, Margaret M. ;
Linehan, David C. ;
Dunne, Richard F. ;
Chang, Daniel T. ;
Koong, Albert C. ;
Hezel, Aram F. ;
Hahn, William C. ;
Shalek, Alex K. ;
Aguirre, Andrew J. ;
Nowak, Jonathan A. ;
Wolpin, Brian M. .
CANCER RESEARCH, 2023, 83 (03) :441-455
[89]  
Wolff Robert A, 2018, Oncotarget, V9, P14764, DOI 10.18632/oncotarget.24483
[90]  
Wu L., 2021, bioRxiv, DOI 10.21.465135v1